Skip to content

Checked

Class IIDrug recallTerminated

Nilotinib active pharmaceutical ingredient recall

Recalled by Attix Pharmaceuticals of Toronto, Canada · FDA report 04/29/2015

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Terminated
Closed 10/07/2015
Recall started
11/14/2014
Distribution
Nationwide

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Nilotinib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Lot and code info
All lots repackaged and distributed between 01/05/12 to 02/12/15
Quantity
10 grams
Recall number
D-817-2015
Event ID
70452
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide to compounding pharmacies and research organizations.

  • Nationwide

Recall timeline

  1. 11/14/2014Firm started the recall
  2. 04/20/2015FDA classified it as Class II
  3. 04/29/2015Published in the FDA enforcement report
  4. 10/07/2015FDA closed (terminated) the recall

All products in this recall

470 products under event 70452

Showing the first 100 of 470 products.

Frequently asked questions

Why was Nilotinib active pharmaceutical ingredient recalled?
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
Nationwide to compounding pharmacies and research organizations.
Is this recall still active?
The FDA lists the recall as terminated (closed 10/07/2015). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 04/29/2015 · Do not rely on openFDA to make decisions regarding medical care